1. Chabner BA, Fine RL, Allegra CJ, Yeh GC, Curt GA: Cancer chemotherapy: Progress and expectations. Cancer (In press).
2. Goldie JH, Coldman AJ: A mathematic model for relating the drug sensitivity of tumors to their spontaneous mutation rate. Cancer Treat. Rep. 63: 1727–1733, 1979.
3. Biedler JF, Peterson PHF: Altered plasma membrane glycoconjugates of Chinese hamster cells with acquired resistance to actinomycin D, daunorubicin and vincristine. IN: Sartorelli AC, Lazlo JS and Bertino JR (eds.) Molecular Actions and Targets for Cancer Chemotherapeutic Agents. Academic Press, New York, pp. 453–482, 1981.
4. Kartner N, Riordan JR, Ling V: Cell surface P-glycoprotein associated with multi-drug resistance in mammalian cell lines. Science 221: 1285–1288, 1983.
5. Tsuruo T, Iida H, Nojiri M, Tsukagoshi S, Sakurai Y: Circumvention of vincristine and adriamycin resistance in vitro and in vivo by calciun influx blockers. Cancer Res. 43: 2905–2910, 1983.